Prevention of Measles

Preventing measles primarily relies on widespread vaccination and public health initiatives.

Measles Vaccination:

• MMR Vaccine: Provides protection against measles, mumps, and rubella.
• Dosage Schedule:
  • First dose: 12-15 months of age
  • Second dose: 4-6 years of age
• Effectiveness:
  • One dose: 93% effective
  • Two doses: 97% effective

Herd Immunity:

• Requires 95% vaccination coverage to prevent outbreaks.
• Protects vulnerable populations who cannot be vaccinated (e.g., infants, immunocompromised individuals).

Strategies to Improve Vaccination Rates:

• Public education campaigns to combat vaccine hesitancy.
• School entry requirements for immunization.
• Global initiatives like the Measles & Rubella Initiative (M&RI).

Addressing Vaccine Hesitancy:

• Provide accurate, science-based information.
• Highlight safety and effectiveness of vaccines.
• Engage community leaders to advocate for immunization.

---

Treatment and Management of Measles

There is no specific antiviral treatment for measles; care focuses on relieving symptoms and managing complications.

Supportive Care:

• Hydration: Prevents dehydration due to fever and diarrhea.
• Fever management: Use acetaminophen or ibuprofen (avoid aspirin).
• Isolation: Prevents further transmission for 4 days after rash onset.

Treating Complications:

• Antibiotics for secondary bacterial infections (e.g., pneumonia, otitis media).
• Hospitalization for severe cases, especially in immunocompromised patients.

Vitamin A Supplementation:

• Recommended for all children with measles, especially in developing countries.
• Dosage:
  • 200,000 IU for children over 12 months.
  • 100,000 IU for infants 6-12 months.
  • 50,000 IU for infants under 6 months.
• Reduces the risk of severe outcomes like blindness and mortality.

---

Measles Outbreaks and Epidemiology

Measles outbreaks continue to pose a public health challenge globally.

Recent Outbreaks:

• Linked to declines in vaccination coverage.
• Higher risk in communities with low immunization rates.
• International travel contributes to virus importation and spread.

Factors Driving Measles Resurgence:

• Vaccine hesitancy and misinformation.
• Health system disruptions (e.g., during the COVID-19 pandemic).
• Global inequities in vaccine access.

Epidemiological Data:

• High-risk groups: Infants, pregnant women, and immunocompromised individuals.
• Global burden: Over 9 million cases annually.
• Mortality rate: Approximately 1-3 in 1,000 cases.

---

Frequently Asked Questions (FAQs) About Measles

1. How long does measles last?

• The illness typically lasts 7-14 days from the onset of symptoms.

2. Can you get measles more than once?

• No, natural infection usually provides lifelong immunity.

3. Is measles dangerous for adults?

• Yes, adults may develop severe complications like pneumonia and encephalitis.

4. What should I do if I am exposed to measles?

• If unvaccinated, receive the MMR vaccine within 72 hours of exposure.
• Immune globulin (IG) may prevent or reduce disease severity if given within 6 days.

5. Are measles and German measles the same?

• No, German measles (rubella) is a separate disease caused by the rubella virus.

---

Conclusion

Measles remains a serious, preventable disease with potential life-threatening complications. Vaccination through the MMR vaccine is the most effective way to protect individuals and communities. Understanding the symptoms, transmission, and prevention methods is crucial to reduce outbreaks and safeguard public health.

Increasing global vaccination coverage and addressing vaccine hesitancy are key to achieving measles eradication. If exposed or experiencing symptoms, prompt medical consultation is essential. Through coordinated public health efforts, we can work toward a future free from measles.

Image Source: Free Malaysia Today
License: CC BY 4.0
Image URL: View Image